Researchers at UMass Chan Medical School are teaming up with pharmaceutical giant Pfizer and the U.S. Food and Drug Administration to study the effects of the COVID-19 drug Paxlovid on patients aged ...

The US Food and Drug Administration on Thursday fully approved the antiviral medication Paxlovid to treat mild to moderate Covid-19 in adults at risk of severe infections. Paxlovid had been available ...

Pfizer’s Paxlovid now has full FDA approval for treating mild-to-moderate Covid-19, a regulatory decision that makes the pill the first oral antiviral for the novel coronavirus. The approval announced ...

The Biden administration will continue to manage the distribution of free courses of Pfizer's Paxlovid treatment for COVID-19 for at least another few months, the drugmaker said, even after the Food ...

WHEN YOU HAVE COVID and aren’t feeling well, you may worry about your symptoms getting worse and that you might end up in the hospital. One option that you have to potentially keep that from happening ...

(Reuters) - The U.S. National Institutes of Health (NIH) said on Monday that it had launched mid-stage clinical trials to test at least four treatments, including Pfizer's Paxlovid, in patients with ...

Covid-19 patients with a history of cardiovascular disease are at an increased risk of developing severe illness and could benefit most from the Covid-19 treatment Paxlovid -- but there's a catch.

Cases of Covid-19 rebound following treatment with the antiviral medication Paxlovid – where infections rev back up again after people complete their five-day course of the medication – appear to be ...